CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 360 of 1
Non-Antibody Products
Page 360 of 1,288
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| 13,14-dihydro-15-keto Prostaglandin F2α-d4 | An internal standard for the quantification of 13,14-dihydro-15-keto PGF2&… | 50 µg | 10007793-50 | More Info |
| 13,14-dihydro-15-keto Prostaglandin F2α-d4 | An internal standard for the quantification of 13,14-dihydro-15-keto PGF2&… | 500 µg | 10007793-500 | More Info |
| 13,14-dihydro-15-keto Prostaglandin F2α ELISA Kit | PGF2α is rapidly metabolized to 13,14-dihydro-15-keto PGF2α in… | 480 Solid | 516671-480SOLIDWELLS | More Info |
| 13,14-dihydro-15-keto Prostaglandin F2α ELISA Kit | PGF2α is rapidly metabolized to 13,14-dihydro-15-keto PGF2α in… | 480 Well | 516671-480STRIPWELLS | More Info |
| 13,14-dihydro-15-keto Prostaglandin F2α ELISA Kit | PGF2α is rapidly metabolized to 13,14-dihydro-15-keto PGF2α in… | 96 Solid | 516671-96SOLIDWELLS | More Info |
| 13,14-dihydro-15-keto Prostaglandin F2α ELISA Kit | PGF2α is rapidly metabolized to 13,14-dihydro-15-keto PGF2α in… | 96 Well | 516671-96STRIPWELLS | More Info |
| 13,14-dihydro-15-keto Prostaglandin J2 | 13,14-dihydro-15-keto PGJ2 is the dehydration product of 13,14-dihydro-15-… | 1 mg | 10008840-1 | More Info |
| 13,14-dihydro-15-keto Prostaglandin J2 | 13,14-dihydro-15-keto PGJ2 is the dehydration product of 13,14-dihydro-15-… | 5 mg | 10008840-5 | More Info |
| 13,14-dihydro-15-keto Prostaglandin J2 | 13,14-dihydro-15-keto PGJ2 is the dehydration product of 13,14-dihydro-15-… | 500 µg | 10008840-500 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin D2 | A potential metabolite of PGD2, presumably produced from the known metabol… | 10 µg | 13100-10 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin D2 | A potential metabolite of PGD2, presumably produced from the known metabol… | 100 µg | 13100-100 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin D2 | A potential metabolite of PGD2, presumably produced from the known metabol… | 25 µg | 13100-25 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin D2 | A potential metabolite of PGD2, presumably produced from the known metabol… | 50 µg | 13100-50 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin E2 | A potential metabolite of PGE2, presumably produced from the known metabol… | 10 µg | 13101-10 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin E2 | A potential metabolite of PGE2, presumably produced from the known metabol… | 25 µg | 13101-25 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin E2 | A potential metabolite of PGE2, presumably produced from the known metabol… | 50 µg | 13101-50 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin F1α | A potential metabolite of either PGF1α or PGF2α and likely pre… | 10 µg | 13571-10 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin F1α | A potential metabolite of either PGF1α or PGF2α and likely pre… | 25 µg | 13571-25 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin F1α | A potential metabolite of either PGF1α or PGF2α and likely pre… | 50 µg | 13571-50 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin F1β | A major urinary metabolite of PGE2 that is excreted in guinea pig urine at… | 10 µg | 16853-10 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin F1β | A major urinary metabolite of PGE2 that is excreted in guinea pig urine at… | 100 µg | 16853-100 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin F1β | A major urinary metabolite of PGE2 that is excreted in guinea pig urine at… | 25 µg | 16853-25 | More Info |
| 13,14-dihydro-15-keto-tetranor Prostaglandin F1β | A major urinary metabolite of PGE2 that is excreted in guinea pig urine at… | 50 µg | 16853-50 | More Info |
| 7,8-dihydro-L-Biopterin | BH2 is a precursor of BH4 synthesis. It is a noncompetitive inhibitor of G… | 10 mg | 81882-10 | More Info |
| 7,8-dihydro-L-Biopterin | BH2 is a precursor of BH4 synthesis. It is a noncompetitive inhibitor of G… | 100 mg | 81882-100 | More Info |
| 7,8-dihydro-L-Biopterin | BH2 is a precursor of BH4 synthesis. It is a noncompetitive inhibitor of G… | 5 mg | 81882-5 | More Info |
| 7,8-dihydro-L-Biopterin | BH2 is a precursor of BH4 synthesis. It is a noncompetitive inhibitor of G… | 50 mg | 81882-50 | More Info |
| Dihydrolipoic Acid | The reduced form of α-lipoic acid that acts as a general antioxidant… | 100 mg | 16372-100 | More Info |
| Dihydrolipoic Acid | The reduced form of α-lipoic acid that acts as a general antioxidant… | 25 mg | 16372-25 | More Info |
| Dihydrolipoic Acid | The reduced form of α-lipoic acid that acts as a general antioxidant… | 50 mg | 16372-50 | More Info |
| Dihydrolipoic Acid | The reduced form of α-lipoic acid that acts as a general antioxidant… | 500 mg | 16372-500 | More Info |
| Dihydrolycorine | A derivative of lycorine with antihypertensive and neuroprotective activit… | 1 mg | 27809-1 | More Info |
| Dihydrolycorine | A derivative of lycorine with antihypertensive and neuroprotective activit… | 10 mg | 27809-10 | More Info |
| Dihydrolycorine | A derivative of lycorine with antihypertensive and neuroprotective activit… | 25 mg | 27809-25 | More Info |
| Dihydrolycorine | A derivative of lycorine with antihypertensive and neuroprotective activit… | 5 mg | 27809-5 | More Info |
| Dihydromethysticin | A kavalactone; a P-gp inhibitor that increases calcein AM uptake by 50% in… | 5 mg | 27644-5 | More Info |
| Dihydromethysticin | An analytical reference standard categorized as a kavalactone; has antinoc… | 1 mg | 33880-1 | More Info |
| Dihydromethysticin | An analytical reference standard categorized as a kavalactone; has antinoc… | 5 mg | 33880-5 | More Info |
| Dihydro Montelukast | A potential impurity found in commercial montelukast preparations, | 1 mg | 22374-1 | More Info |
| Dihydro Montelukast | A potential impurity found in commercial montelukast preparations, | 500 µg | 22374-500 | More Info |
| Dihydromorphine (exempt preparation) | An analytical reference standard categorized as an opioid; an active metab… | 1 mg | 22881-1 | More Info |
| Dihydromyricetin | A flavanonol with diverse biological activities; scavenges DPPH radicals (… | 10 mg | 23549-10 | More Info |
| Dihydromyricetin | A flavanonol with diverse biological activities; scavenges DPPH radicals (… | 25 mg | 23549-25 | More Info |
| Dihydromyricetin | A flavanonol with diverse biological activities; scavenges DPPH radicals (… | 5 mg | 23549-5 | More Info |
| Dihydromyricetin | A flavanonol with diverse biological activities; scavenges DPPH radicals (… | 50 mg | 23549-50 | More Info |
| Dihydromyristicin | A derivative of myristicin; induces GST activity in the liver and small in… | 10 mg | 39272-10 | More Info |
| Dihydromyristicin | A derivative of myristicin; induces GST activity in the liver and small in… | 25 mg | 39272-25 | More Info |
| Dihydromyristicin | A derivative of myristicin; induces GST activity in the liver and small in… | 5 mg | 39272-5 | More Info |
| Dihydromyristicin | A derivative of myristicin; induces GST activity in the liver and small in… | 50 mg | 39272-50 | More Info |
| 3,4-dihydro Naratriptan | A process impurity formed during the preparation of naratriptan | 10 mg | 17890-10 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile